The Liver Meeting® (TLM) 2026, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), will be held at the Colorado Convention Center in Denver, Colorado, Thursday, November 5 through Monday, November 9, 2026.

The Liver Meeting brings together hepatologists, gastroenterologists, transplant specialists, hepatology associates, researchers and trainees from around the world for the latest science and clinical practice in liver disease, including the Annual Postgraduate Course, plenary and parallel sessions, poster presentations, satellite symposia and the TLM Theater.

Voxmedia will present a CME satellite symposium during The Liver Meeting. See the symposium listing on this calendar for details and registration.

A CME Satellite Symposium during The Liver Meeting® 2026 of the American Association for the Study of Liver Diseases (AASLD) in Denver, Colorado.

Lunch and Symposium: 12:00–1:30 PM MT

AGENDA

12:00 PM            Introduction
                           Arun Sanyal, MD (Chair)

12:05 PM            From Metabolic Risk to Fibrosis Stage – Implementing the NIT Framework in Hepatology Practice
                           Mary Rinella, MD

12:25 PM            Resmetirom and Semaglutide in Clinical Practice
                           Rohit Loomba, MD, MHSc

12:45 PM            The FGF21 Analog Class – Mechanism, Evidence, and the Compensated Cirrhosis Challenge
                           Mazen Noureddin, MD, MHSc

1:05 PM              Case Discussions
                           Presenter: Arun Sanyal, MD
                           Panelists: Rohit Loomba, MD, MHSc; Mazen Noureddin, MD, MHSc; Mary Rinella, MD

1:20 PM              Question and Answer

EDUCATIONAL OBJECTIVES

■ Apply the AASLD-endorsed stepwise non-invasive testing framework — including FIB-4, VCTE/ELF, and MRE — to identify patients with MASH and significant fibrosis (F2–F3) who are candidates for pharmacotherapy, and describe the role of liver biopsy in cases of diagnostic uncertainty
■ Compare the mechanism of action, Phase 3 clinical evidence, patient selection criteria, and monitoring requirements for resmetirom and semaglutide 2.4 mg/week in patients with non-cirrhotic MASH and F2–F3 fibrosis, and apply this comparison to individualized treatment decisions based on patient comorbidity profile
■ Characterize the FGF21 analog class — including efruxifermin and pegozafermin — by mechanism of action, Phase 2 and Phase 3 evidence to date, and current regulatory status, and describe the evidence supporting the investigational role of FGF21 analogs in patients with pre-cirrhotic MASH and compensated cirrhosis due to MASH
■ Formulate an evidence-based management plan for patients with compensated MASH cirrhosis, including surveillance priorities, appropriate use of approved therapies for comorbid conditions, and accurate patient communication regarding investigational treatment options

TARGET AUDIENCE

This program is targeted to hepatologists and gastroenterologists and other advanced practice providers practicing in hepatology and gastroenterology.

ACCREDITATION AND CREDIT DESIGNATION

Voxmedia, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Grant

Voxmedia International gratefully acknowledges the educational grant provided by Novo Nordisk Inc.

CHAIR

Arun Sanyal, MD
Chief, Division of Gastroenterology, Hepatology, and Nutrition
Professor of Medicine, Physiology and Molecular Pathology
Virginia Commonwealth University School of Medicine
Richmond, Virginia

FACULTY

Rohit Loomba, MD, MHSc
Chief, Division of Gastroenterology and Hepatology
Director, UC San Diego MASLD Research Center
Professor of Medicine
UC San Diego Health
San Diego, California

Mazen Noureddin, MD, MHSc
Professor of Medicine
Sherry and Alan Conover Center for Liver Disease & Transplantation
Underwood Center for Digestive Health
J.C. Walter Jr. Transplant Center
Houston Methodist
Houston, Texas

Mary Rinella, MD
Professor of Medicine
Director, Metabolic and Fatty Liver Disease
The University of Chicago Medicine
Chicago, Illinois

This event is provided by Voxmedia LLC and supported by Novo Nordisk. This is not an official event/function of the American Association for the Study of Liver Diseases.

The Liver Meeting® (TLM) 2026, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), will be held at the Colorado Convention Center in Denver, Colorado, Thursday, November 5 through Monday, November 9, 2026.

The Liver Meeting brings together hepatologists, gastroenterologists, transplant specialists, hepatology associates, researchers and trainees from around the world for the latest science and clinical practice in liver disease, including the Annual Postgraduate Course, plenary and parallel sessions, poster presentations, satellite symposia and the TLM Theater.

Voxmedia will present a CME satellite symposium during The Liver Meeting. See the symposium listing on this calendar for details and registration.

Why Attend

Be a part of the premier global event for advancements in cardiovascular science and medicine. Experience the highest tier of scientific discovery and practice-changing educational content. Focus on your specialty and engage with experts, or expand your knowledge through discussions, resources and interaction with notable peers.

This conference is focused on the latest innovations for scientists, clinicians, researchers and other healthcare professionals interested in any and all aspects of cardiovascular disease. Discover the robust scientific and clinical learning portfolio of programming across an array of specialties. Network with a multitude of colleagues at the conference known for playing a pivotal role in training young and diverse researchers. Learn and participate through the greater mission of the American Heart Association: to be a relentless force for a world of longer, healthier lives.

What You'll Gain at Scientific Sessions

• Unmatched science: 5,000+ presentations across 21 specialties with access extended through OnDemand™
• Global Collaboration: Attendees from 100+ countries, building connections that drive global impact
• Practical Insight: Clinical guidance, real-world application, and evidence-based takeaways
• Bold New Voices: New format brings emerging leaders and ideas to the forefront
• Tools You Can Use: Simulation, AI, and guideline-focused experiences you won't find anywhere else
• Real Community: From Council dinners to mentor meetups, this is where science meets connection 

Location

The meeting will be held at the McCormick Place Convention Center in Chicago, Illinois.

2301 S Dr Martin Luther King Jr Dr

Chicago, IL

A CME Symposium during the 2026 American Heart Association (AHA) Scientific Sessions in Chicago, Illinois.

Dinner and Registration: 5:30–6:00 PM CT
Symposium: 6:00–7:30 PM CT

AGENDA

6:00 PM            Introduction
                           Paul Ridker, MD, MPH (Chair)

6:10 PM            Inflammation in ASCVD—The Biology, The Biomarker, and the Evidence
                           Paul Ridker, MD, MPH

6:30 PM            Inflammation in ASCVD: The Current Therapeutic Landscape
                           Jean-Claude Tardif, MD

6:45 PM            Inflammation in Cardiovascular-Kidney-Metabolic (CKM) Syndrome
                           Katherine Tuttle, MD

7:00 PM            Panel Discussion/Question and Answer

7:25 PM            Concluding Remarks

EDUCATIONAL OBJECTIVES

■ Describe the role of the IL-1β→IL-6→CRP inflammatory pathway in atherosclerotic plaque progression and rupture, and explain the clinical evidence supporting hsCRP as an independent predictor of recurrent MACE in statin-treated patients with ASCVD
■ Identify patients across cardiology subspecialties with established ASCVD and residual inflammatory risk, and apply a structured hsCRP screening and interpretation framework to clinical decision-making
■ Discuss the mechanism, clinical outcomes evidence, safety profile, and appropriate patient selection for low-dose colchicine as the current standard of evidence-based anti-inflammatory secondary prevention
■ Recognize that inflammation is not only a central mediator in the pathological progression of CKM syndrome but also a pivotal molecular hub that drives coordinated damage across multiple organ systems

TARGET AUDIENCE

This program is intended for cardiovascular clinicians.

ACCREDITATION AND CREDIT DESIGNATION

Voxmedia, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Grant

Voxmedia International gratefully acknowledges the educational grant provided by Novo Nordisk Inc.

CHAIR

Paul M. Ridker, MD, MPH
Eugene Braunwald Professor of Medicine
Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Brigham and Women’s Hospital
Boston, Massachusetts

FACULTY

Jean-Claude Tardif, CM, MD
Professor of Medicine
Université de Montréal
Director
Montreal Heart Institute Research Centre
Montreal, Quebec, Canada

Katherine Tuttle, MD
Executive Director for Research
Providence Inland Northwest Health
Spokane, Washington
Professor of Medicine
University of Washington School of Medicine
Seattle, Washington

This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming.

The Liver Meeting® (TLM) 2026, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), will be held at the Colorado Convention Center in Denver, Colorado, Thursday, November 5 through Monday, November 9, 2026.

The Liver Meeting brings together hepatologists, gastroenterologists, transplant specialists, hepatology associates, researchers and trainees from around the world for the latest science and clinical practice in liver disease, including the Annual Postgraduate Course, plenary and parallel sessions, poster presentations, satellite symposia and the TLM Theater.

Voxmedia will present a CME satellite symposium during The Liver Meeting. See the symposium listing on this calendar for details and registration.

Why Attend

Be a part of the premier global event for advancements in cardiovascular science and medicine. Experience the highest tier of scientific discovery and practice-changing educational content. Focus on your specialty and engage with experts, or expand your knowledge through discussions, resources and interaction with notable peers.

This conference is focused on the latest innovations for scientists, clinicians, researchers and other healthcare professionals interested in any and all aspects of cardiovascular disease. Discover the robust scientific and clinical learning portfolio of programming across an array of specialties. Network with a multitude of colleagues at the conference known for playing a pivotal role in training young and diverse researchers. Learn and participate through the greater mission of the American Heart Association: to be a relentless force for a world of longer, healthier lives.

What You'll Gain at Scientific Sessions

• Unmatched science: 5,000+ presentations across 21 specialties with access extended through OnDemand™
• Global Collaboration: Attendees from 100+ countries, building connections that drive global impact
• Practical Insight: Clinical guidance, real-world application, and evidence-based takeaways
• Bold New Voices: New format brings emerging leaders and ideas to the forefront
• Tools You Can Use: Simulation, AI, and guideline-focused experiences you won't find anywhere else
• Real Community: From Council dinners to mentor meetups, this is where science meets connection 

Location

The meeting will be held at the McCormick Place Convention Center in Chicago, Illinois.

2301 S Dr Martin Luther King Jr Dr

Chicago, IL

A CME Symposium during the 2026 American Heart Association (AHA) Scientific Sessions in Chicago, Illinois.

Dinner and Registration: 5:30–6:00 PM CT
Symposium: 6:00–7:30 PM CT

AGENDA

6:00 PM            Introduction
                           Mathew Maurer, MD (Chair)

6:10 PM            When Should I Think Transthyretin Cardiac Amyloidosis? Red Flags and Keys to Early Diagnosis
                           Sarah Cuddy, MD, MPH

6:30 PM            The Changing Treatment Landscape for ATTR-CM
                           Ahmad Masri, MD, MS

6:50 PM            Navigating the Complexities of ATTR-CM Management: Practice Pearls
                           Case #1: Avoiding Pitfalls and Overcoming Challenges
                           Justin Grodin, MD, MPH
                           Case #2: Getting to the Heart of the Matter: Challenges and Opportunities in Early Detection of ATTRv-CM
                           Mathew Maurer, MD

7:15 PM            Question and Answer

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants should be able to:

■ Identify suggestive findings for ATTR-CM
■ Summarize the diagnostic evaluation for cardiac amyloidosis
■ Interpret the evidence for ATTR-CM disease-modifying therapies
■ Discuss strategies for the use of HF medications in patients diagnosed with ATTR-CM
■ Explain the importance of genetic testing in the diagnosis of ATTR-CM
■ Describe the challenges associated with the management of transthyretin amyloidosis

TARGET AUDIENCE

This educational activity is intended for cardiovascular clinicians.

ACCREDITATION AND CREDIT DESIGNATION

Voxmedia, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Grant

Voxmedia gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals LP and Ionis Pharmaceuticals.

CHAIR

Mathew Maurer, MD
Arnold and Arlene Goldstein Professor of Cardiology
Professor of Medicine
Columbia University Irving Medical Center
Vagelos College of Physicians & Surgeons
New York, New York

FACULTY

Sarah Cuddy, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Justin Grodin, MD, MPH
Associate Professor of Medicine
Department of Internal Medicine – Division of Cardiology
University of Texas Southwestern Medical Center
Dallas, Texas

Ahmad Masri, MD, MS
Associate Professor of Medicine
Oregon Health & Science University
Portland, Oregon

This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming.

The Liver Meeting® (TLM) 2026, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), will be held at the Colorado Convention Center in Denver, Colorado, Thursday, November 5 through Monday, November 9, 2026.

The Liver Meeting brings together hepatologists, gastroenterologists, transplant specialists, hepatology associates, researchers and trainees from around the world for the latest science and clinical practice in liver disease, including the Annual Postgraduate Course, plenary and parallel sessions, poster presentations, satellite symposia and the TLM Theater.

Voxmedia will present a CME satellite symposium during The Liver Meeting. See the symposium listing on this calendar for details and registration.

Why Attend

Be a part of the premier global event for advancements in cardiovascular science and medicine. Experience the highest tier of scientific discovery and practice-changing educational content. Focus on your specialty and engage with experts, or expand your knowledge through discussions, resources and interaction with notable peers.

This conference is focused on the latest innovations for scientists, clinicians, researchers and other healthcare professionals interested in any and all aspects of cardiovascular disease. Discover the robust scientific and clinical learning portfolio of programming across an array of specialties. Network with a multitude of colleagues at the conference known for playing a pivotal role in training young and diverse researchers. Learn and participate through the greater mission of the American Heart Association: to be a relentless force for a world of longer, healthier lives.

What You'll Gain at Scientific Sessions

• Unmatched science: 5,000+ presentations across 21 specialties with access extended through OnDemand™
• Global Collaboration: Attendees from 100+ countries, building connections that drive global impact
• Practical Insight: Clinical guidance, real-world application, and evidence-based takeaways
• Bold New Voices: New format brings emerging leaders and ideas to the forefront
• Tools You Can Use: Simulation, AI, and guideline-focused experiences you won't find anywhere else
• Real Community: From Council dinners to mentor meetups, this is where science meets connection 

Location

The meeting will be held at the McCormick Place Convention Center in Chicago, Illinois.

2301 S Dr Martin Luther King Jr Dr

Chicago, IL

The Liver Meeting® (TLM) 2026, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), will be held at the Colorado Convention Center in Denver, Colorado, Thursday, November 5 through Monday, November 9, 2026.

The Liver Meeting brings together hepatologists, gastroenterologists, transplant specialists, hepatology associates, researchers and trainees from around the world for the latest science and clinical practice in liver disease, including the Annual Postgraduate Course, plenary and parallel sessions, poster presentations, satellite symposia and the TLM Theater.

Voxmedia will present a CME satellite symposium during The Liver Meeting. See the symposium listing on this calendar for details and registration.

Why Attend

Be a part of the premier global event for advancements in cardiovascular science and medicine. Experience the highest tier of scientific discovery and practice-changing educational content. Focus on your specialty and engage with experts, or expand your knowledge through discussions, resources and interaction with notable peers.

This conference is focused on the latest innovations for scientists, clinicians, researchers and other healthcare professionals interested in any and all aspects of cardiovascular disease. Discover the robust scientific and clinical learning portfolio of programming across an array of specialties. Network with a multitude of colleagues at the conference known for playing a pivotal role in training young and diverse researchers. Learn and participate through the greater mission of the American Heart Association: to be a relentless force for a world of longer, healthier lives.

What You'll Gain at Scientific Sessions

• Unmatched science: 5,000+ presentations across 21 specialties with access extended through OnDemand™
• Global Collaboration: Attendees from 100+ countries, building connections that drive global impact
• Practical Insight: Clinical guidance, real-world application, and evidence-based takeaways
• Bold New Voices: New format brings emerging leaders and ideas to the forefront
• Tools You Can Use: Simulation, AI, and guideline-focused experiences you won't find anywhere else
• Real Community: From Council dinners to mentor meetups, this is where science meets connection 

Location

The meeting will be held at the McCormick Place Convention Center in Chicago, Illinois.

2301 S Dr Martin Luther King Jr Dr

Chicago, IL